Skip to content
NIFTY 5023,842.75+0.54%SENSEX78,553.20+0.54%NIFTY BANK51,236.80-0.17%NIFTY IT33,156.40+0.75%NIFTY PHARMA19,872.35+0.28%NIFTY AUTO23,145.90-0.48%NIFTY FMCG56,234.15+0.32%INDIA VIX13.42-2.75%NIFTY 5023,842.75+0.54%SENSEX78,553.20+0.54%NIFTY BANK51,236.80-0.17%NIFTY IT33,156.40+0.75%NIFTY PHARMA19,872.35+0.28%NIFTY AUTO23,145.90-0.48%NIFTY FMCG56,234.15+0.32%INDIA VIX13.42-2.75%
BarakFi
ScreenerExploreToolsWatchlist
Log inGet started
Loading stock detail

Preparing the latest stock view…

We're pulling the screening verdict, quote snapshot, and company context now.

Is NATCO Pharma Limited Shariah Compliant? | BarakFi | BarakFi
NIFTY 5023,842.75+0.54%SENSEX78,553.20+0.54%NIFTY BANK51,236.80-0.17%NIFTY IT33,156.40+0.75%NIFTY PHARMA19,872.35+0.28%NIFTY AUTO23,145.90-0.48%NIFTY FMCG56,234.15+0.32%INDIA VIX13.42-2.75%NIFTY 5023,842.75+0.54%SENSEX78,553.20+0.54%NIFTY BANK51,236.80-0.17%NIFTY IT33,156.40+0.75%NIFTY PHARMA19,872.35+0.28%NIFTY AUTO23,145.90-0.48%NIFTY FMCG56,234.15+0.32%INDIA VIX13.42-2.75%
BarakFi
ScreenerExploreToolsWatchlist
Log inGet started
Home›Screener›NATCOPHARM
NATCOPHARM logo
NATCOPHARMNSE

NATCO Pharma Limited

Pharmaceuticals · Mid Cap · India
₹1,175
▲ ₹18.7 (+1.62%) today
Day Range: ₹1,149.9 – ₹1,192.5
Volume: — · as of 22 May 2026, 8:26 am
Shariah Status
Not Compliant
Report Credit
Opening this stock page uses 1 of your 50 monthly report credits.
Last screened 22 May 2026, 7:36 pm IST.
Methodology
AAOIFI aligned · 2026.04.2
See Full Breakdown
Not Compliant
Compliance
Market Data
About
Similar Stocks
Add to Watchlist
Share
Shariah Compliance Breakdown
Debt Ratio
Interest-bearing debt compared to methodology denominator (AAOIFI: total assets). Must stay below 30%.
Disclaimer:The information on this page is for educational purposes only and does not constitute a religious ruling (fatwa) or financial advice. Shariah compliance status is derived from publicly available financial data and BarakFi's methodology mapping. Individual scholars may reach different conclusions. Always consult a qualified Islamic finance scholar and a licensed financial advisor before making investment decisions.
BarakFi
Shariah-compliant stock research for Indian equities. Educational only.
Product
ScreenerWatchlistCompare
Learn
MethodologyAbout
Legal
PrivacyDisclaimer
© 2026 BarakFi · Educational screening · Not a religious ruling or financial adviceMade in India
Threshold: 30%
3.2%
Pass
Interest Income
Interest and treasury-based income as a share of business income. Must stay below 5%.
Threshold: 5%
4.2%
Borderline
Non-permissible Income
Non-halal income compared to total business income. Must stay below 5%.
Threshold: 5%
4.2%
Borderline
Accounts Receivable
Receivables compared to methodology denominator (AAOIFI: total assets). Must stay below 49%.
Threshold: 49%
14.4%
Pass
Business Activity
Core business lines should avoid prohibited sectors and interest-driven revenue dependence.
Allowed
Pass
Cash & Interest-bearing Assets
Cash, equivalents, and interest-bearing balances compared to total assets. Must stay below 30%.
Threshold: 30%
32.5%
Fail
Why Not Compliant
NATCO Pharma Limited currently screens as not compliant on BarakFi. Cash & interest-bearing securities are 32.5% of total assets, exceeding the 30% limit under AAOIFI.
Market Data
Current Price
₹1,175
Day Range
₹1,149.9 – ₹1,192.5
52-Week Range
₹789 – ₹1,226.8
Volume
15.4 L
Market Cap
₹19,466 Cr
P/E Ratio
12.5×
About NATCO Pharma Limited

NATCO Pharma Limited (NATCOPHARM) is listed on NSE and operates in the Pharmaceuticals sector, with BarakFi classifying it as a mid cap name in India.

This page brings together filing-driven screening ratios, market-cap context, and live quote snapshots so you can review the stock from a Shariah-screening perspective without losing the company and market background around it.

Index and universe context: Nifty 500 • Nifty MIDCAP 100.

PharmaceuticalsMid CapIndiaNSENifty 500Nifty MIDCAP 100
Other Stocks in Pharmaceuticals
No nearby sector peers available yet.
Key Compliance Ratios
Debt Ratio3.2%
Interest Income4.2%
Non-permissible Income4.2%
Receivables Ratio14.4%
Overall StatusNot Compliant
Stock Information
TickerNATCOPHARM
ExchangeNSE
SectorPharmaceuticals
CountryIndia
Market Cap₹19,466 Cr
36M Avg MCap₹17,572 Cr
Cap SizeMid Cap
About this Screening
This page uses an AAOIFI-aligned methodology version 2026.04.2, checking debt, interest income, non-permissible income, receivables, and balance-sheet context from the current filings dataset.

This is educational only — not a religious ruling or financial advice. Read the full methodology for threshold context and update cadence.

Read full methodology →
Track this stock
Add NATCOPHARM to your watchlist so you can revisit its status after the next fundamentals sync.
Open Watchlist